MedTrace Logo

Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study

NCT06522880 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-07-26

No results posted yet for this study

Summary

The goal of STAGE I of the CMV TransmIT Study is to determine the prevalence of CMV shedding in children up to and including 36 months of age in large group childcare centers and in staff who regularly work at the center. Participants will complete a health survey and provide one saliva sample for CMV PCR testing. In addition, infrastructure for the study will be developed (e.g. community engagement to build the network of centers, data pipelines, digital platform, sampling workflows) and participant sample collection at home will be piloted. These activities will inform the design of STAGE II.

Conditions

  • Cytomegalovirus Infections

Interventions

DIAGNOSTIC_TEST

CMV PCR on saliva

Observational study to measure prevalence of CMV shedding by saliva PCR

Sponsors & Collaborators

  • ModernaTX, Inc.

    collaborator INDUSTRY

  • University of Massachusetts, Worcester

    lead OTHER

Principal Investigators

  • Laura Gibson, MD · UMass Chan Medical School

Eligibility

Min Age
1 Day
Max Age
36 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-10
Primary Completion
2027-01-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06522880 on ClinicalTrials.gov